1. Home
  2. GHLD vs GERN Comparison

GHLD vs GERN Comparison

Compare GHLD & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHLD
  • GERN
  • Stock Information
  • Founded
  • GHLD 1960
  • GERN 1990
  • Country
  • GHLD United States
  • GERN United States
  • Employees
  • GHLD N/A
  • GERN N/A
  • Industry
  • GHLD Finance: Consumer Services
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • GHLD Finance
  • GERN Health Care
  • Exchange
  • GHLD Nasdaq
  • GERN Nasdaq
  • Market Cap
  • GHLD 977.9M
  • GERN 974.5M
  • IPO Year
  • GHLD 2020
  • GERN 1996
  • Fundamental
  • Price
  • GHLD $19.85
  • GERN $1.28
  • Analyst Decision
  • GHLD Hold
  • GERN Buy
  • Analyst Count
  • GHLD 6
  • GERN 8
  • Target Price
  • GHLD $17.90
  • GERN $3.71
  • AVG Volume (30 Days)
  • GHLD 145.3K
  • GERN 9.4M
  • Earning Date
  • GHLD 08-07-2025
  • GERN 08-07-2025
  • Dividend Yield
  • GHLD 2.52%
  • GERN N/A
  • EPS Growth
  • GHLD 63.18
  • GERN N/A
  • EPS
  • GHLD 0.71
  • GERN N/A
  • Revenue
  • GHLD $1,131,796,000.00
  • GERN $116,293,000.00
  • Revenue This Year
  • GHLD $5.64
  • GERN $160.12
  • Revenue Next Year
  • GHLD $26.37
  • GERN $55.01
  • P/E Ratio
  • GHLD $27.85
  • GERN N/A
  • Revenue Growth
  • GHLD 32.57
  • GERN 22264.04
  • 52 Week Low
  • GHLD $11.21
  • GERN $1.17
  • 52 Week High
  • GHLD $20.15
  • GERN $5.06
  • Technical
  • Relative Strength Index (RSI)
  • GHLD 81.32
  • GERN 41.10
  • Support Level
  • GHLD $19.79
  • GERN $1.36
  • Resistance Level
  • GHLD $20.02
  • GERN $1.48
  • Average True Range (ATR)
  • GHLD 0.07
  • GERN 0.08
  • MACD
  • GHLD -0.18
  • GERN -0.02
  • Stochastic Oscillator
  • GHLD 43.33
  • GERN 7.41

About GHLD Guild Holdings Company

Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: